Trial Profile
A comparison study of combined ECT [electroconvulsive therapy] and risperidone versus ECT alone for treatment resistant depression
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2007
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 31 Dec 2005 New trial record.